Evidence map›Paper›PMID 34836021›Full record

ReviewNutrients2021

Nanae Ishida, Hidetoshi Yamada, Masamichi Hirose

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Protection ofNutrients · 2023
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nanae IshidaDepartment of Pathophysiology and Pharmacology, School of Pharmaceutical Sciences, Iwate Medical University, Iwate 028-3694, Japan.
Hidetoshi YamadaFaculty of Life & Environmental Science, Teikyo University of Science, Tokyo 120-0045, Japan.
Masamichi HiroseDepartment of Pathophysiology and Pharmacology, School of Pharmaceutical Sciences, Iwate Medical University, Iwate 028-3694, Japan.ORCID 0000-0001-5742-2245
Iwate Medical University · JPTeikyo University of Science · JP

Funding

Technology Agency and Project of the NARO Bio-oriented Technology Research Advancement In-stitution (special scheme project on vitalizing management entities of agriculture, forestry, and fisheries) 0000
6 · The paper itself

Abstract

Marine n-3 fatty acids are well known to have health benefits. Recently, krill oil, which contains phospholipids, has been in the spotlight as an n-3 PUFA-containing oil.

Indexed as

AnimalsAtherosclerosisDyslipidemiasEicosapentaenoic AcidEuphausiaceaFish OilsHumansLiverMetabolic SyndromeMiceNon-alcoholic Fatty Liver DiseasePPAR alphaPPAR deltaPPAR gammaEicosapentaenoic AcidFish OilsPPAR alphaPPAR deltaPPAR gamma8-HEPEEuphausia pacificaN-3 polyunsaturated fatty acidsnonalcoholic fatty liver disease

Identifiers

PMID34836021
PMCPMC8618228
OpenAlexW3210576761

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.